ConductScience.org, home

Paper30680929

Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.

Hu S and 7 others. J Cell Mol Med, 2019. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway. Papers, record 30680929. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30680929

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.
PubMed
Journal
J Cell Mol Med
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.43
iCite
Revised in PubMed
2023-07-03
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hu SShanhttps://orcid.org/0000-0003-2984-5317
2Cheng MMian
3Guo XXin
4Wang SShun
5Liu BBeilei
6Jiang HHong
7Huang CCongxin
8Wu GGang

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin IIMajor topic
AortaMajor topic
CardiomegalyMajor topic
MicroRNAsMajor topic
Myocytes, CardiacMajor topic
Myosin-Light-Chain KinaseMajor topic
Animals
Antagomirs
Apoptosis
Constriction, Pathologic
Disease Models, Animal
Echocardiography
Gene Expression Regulation
Male
Oligoribonucleotides
Primary Cell Culture
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species
Signal Transduction

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in37395337Correction to Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.https://conductscience.org/library/papers/37395337

Source PubMed

Download CSV of comments and corrections

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126497329Glucose Fluctuations Aggravate Cardiac Susceptibility to Ischemia/Reperfusion Injury by Modulating MicroRNAs Expression.Circ J2016https://conductscience.org/library/papers/26497329PubMed
230680929Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.J Cell Mol Med2019https://conductscience.org/library/papers/30680929PubMed
321527937miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition.Cell Death Differ2011https://conductscience.org/library/papers/21527937PubMed
417804704Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.Cancer Res2007https://conductscience.org/library/papers/17804704PubMed
521345328The significance of regulatory light chain phosphorylation in cardiac physiology.Arch Biochem Biophys2011https://conductscience.org/library/papers/21345328PubMed
628700997Nobiletin, a Polymethoxy Flavonoid, Protects Against Cardiac Hypertrophy Induced by Pressure-Overload via Inhibition of NAPDH Oxidases and Endoplasmic Reticulum Stress.Cell Physiol Biochem2017https://conductscience.org/library/papers/28700997PubMed
728494450Stachydrine Protects Against Pressure Overload-Induced Cardiac Hypertrophy by Suppressing Autophagy.Cell Physiol Biochem2017https://conductscience.org/library/papers/28494450PubMed
829262413Angiotensin II Facilitates Matrix Metalloproteinase-9-Mediated Myosin Light Chain Kinase Degradation in Pressure Overload-Induced Cardiac Hypertrophy.Cell Physiol Biochem2017https://conductscience.org/library/papers/29262413PubMed
924481846Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure.Circ Res2014https://conductscience.org/library/papers/24481846PubMed
1028391263Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway.Cell Physiol Biochem2017https://conductscience.org/library/papers/28391263PubMed
1123095280Myosin light chain phosphorylation is critical for adaptation to cardiac stress.Circulation2012https://conductscience.org/library/papers/23095280PubMed
1228164119Sodium Ferulate Protects against Angiotensin II-Induced Cardiac Hypertrophy in Mice by Regulating the MAPK/ERK and JNK Pathways.Biomed Res Int2017https://conductscience.org/library/papers/28164119PubMed
1310655107Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro.Nat Med2000https://conductscience.org/library/papers/10655107PubMed
1428837147Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells.Cell Death Dis2017https://conductscience.org/library/papers/28837147PubMed
1528770953MicroRNA-200c exacerbates the ischemia/reperfusion injury of heart through targeting the glutaminase (GLS)-mediated glutamine metabolism.Eur Rev Med Pharmacol Sci2017https://conductscience.org/library/papers/28770953PubMed
1627443826Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation.Sci Rep2016https://conductscience.org/library/papers/27443826PubMed
1718202317Identification of cardiac-specific myosin light chain kinase.Circ Res2008https://conductscience.org/library/papers/18202317PubMed
1826334100The ZEB1/miR-200c feedback loop regulates invasion via actin interacting proteins MYLK and TKS5.Oncotarget2015https://conductscience.org/library/papers/26334100PubMed
1927565029miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.J Mol Cell Cardiol2016https://conductscience.org/library/papers/27565029PubMed
2025850725MicroRNA-101 inhibits rat cardiac hypertrophy by targeting Rab1a.J Cardiovasc Pharmacol2015https://conductscience.org/library/papers/25850725PubMed

See all 43 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
41235503The Network of Exosomes miRNA and p-MLC2 Regulatory Pathway Induced Pathological Cardiac Hypertrophy in Vasn Deficient Mice.J Cell Mol Med2025https://conductscience.org/library/papers/41235503PubMed
40341377Divergent Cardiovascular Adaptations and Gene Regulation in High-Elevation Natives and Recent Colonizers of the Qinghai-Tibetan Plateau.Mol Biol Evol2025https://conductscience.org/library/papers/40341377PubMed
37395337Correction to Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.J Cell Mol Med2023https://conductscience.org/library/papers/37395337PubMed
35703318lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway.Bioengineered2022https://conductscience.org/library/papers/35703318PubMed
35384363Loss of cardiac myosin light chain kinase contributes to contractile dysfunction in right ventricular pressure overload.Physiol Rep2022https://conductscience.org/library/papers/35384363PubMed
35378949Myosin Light Chain Kinase Modulates to Improve Myocardial Hypoxia/Reoxygenation Injury.J Healthc Eng2022https://conductscience.org/library/papers/35378949PubMed
35348441MicroRNA miR-27a-3p accelerates cardiac hypertrophy by targeting neuro-oncological ventral antigen 1.Bioengineered2022https://conductscience.org/library/papers/35348441PubMed
34854218Vasorin deficiency leads to cardiac hypertrophy by targeting MYL7 in young mice.J Cell Mol Med2022https://conductscience.org/library/papers/34854218PubMed
34594408TFEC contributes to cardiac hypertrophy by inhibiting AMPK/mTOR signaling.Exp Ther Med2021https://conductscience.org/library/papers/34594408PubMed
34153234Amniotic fluid microRNA profiles in twin-twin transfusion syndrome with and without severe recipient cardiomyopathy.Am J Obstet Gynecol2021https://conductscience.org/library/papers/34153234PubMed
33748196Myocardial Infarction: The Protective Role of MiRNAs in Myocardium Pathology.Front Cardiovasc Med2021https://conductscience.org/library/papers/33748196PubMed
33732347Piperine protects against myocardial ischemia/reperfusion injury by activating the PI3K/AKT signaling pathway.Exp Ther Med2021https://conductscience.org/library/papers/33732347PubMed
32575472MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.Int J Mol Sci2020https://conductscience.org/library/papers/32575472PubMed
32468736Up-regulation of miR-195 contributes to cardiac hypertrophy-induced arrhythmia by targeting calcium and potassium channels.J Cell Mol Med2020https://conductscience.org/library/papers/32468736PubMed
31929856The Oxidative Stress-Induced miR-200c Is Upregulated in Psoriasis and Correlates with Disease Severity and Determinants of Cardiovascular Risk.Oxid Med Cell Longev2019https://conductscience.org/library/papers/31929856PubMed
31840653Long Noncoding RNA FTX Reduces Hypertrophy of Neonatal Mouse Cardiac Myocytes and Regulates the PTEN/PI3K/Akt Signaling Pathway by Sponging MicroRNA-22.Med Sci Monit2019https://conductscience.org/library/papers/31840653PubMed
31636246MD-1 Deficiency Accelerates Myocardial Inflammation and Apoptosis in Doxorubicin-Induced Cardiotoxicity by Activating the TLR4/MAPKs/Nuclear Factor kappa B (NF-κB) Signaling Pathway.Med Sci Monit2019https://conductscience.org/library/papers/31636246PubMed
31547607MicroRNAs in Cardiac Hypertrophy.Int J Mol Sci2019https://conductscience.org/library/papers/31547607PubMed
30680929Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.J Cell Mol Med2019https://conductscience.org/library/papers/30680929PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
MIR200C406985PubTator's text mininghttps://conductscience.org/library/genes/406985NCBI Gene
MYL24633PubTator's text mininghttps://conductscience.org/library/genes/4633NCBI Gene
MYLK4638PubTator's text mininghttps://conductscience.org/library/genes/4638NCBI Gene
MYLK391807PubTator's text mininghttps://conductscience.org/library/genes/91807NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30680929

GET https://conductscience.org/api/papers/v1/30680929/references?page=2